Findings: Summary As expected, semaglutide-induced weight loss improved knee pain and function in a predominantly female population (82%) with moderate knee OA
In the STEP-1 semaglutide trial, roughly 39% of the weight lost was lean mass in the DEXA substudy ( Wilding et al., NEJM 2021 )
AND NOW FOR THE CONTROVERSY: DOES IGF-1 DECREASE LONGEVITY
About the Author: Dr
In a highly litigious atmosphere, with several major compounding players opting not to test the limits of whats legally permissible, there will indeed be a significant subset of patients who struggle to find accessible, affordable meds
It supports your bodys natural GLP-1 pathways, which can help with satiety, cravings, and metabolic balance - all of which can absolutely support your goals when paired with healthy habits.